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Purpose: Microbial infections often produce pain and inflammation. Chemotherapeutic, analgesic and 
anti-inflammatory drugs are prescribed simultaneously in normal practice. The compound possessing all 
three activities is not common.The purpose of the present study was to examine whether molecular 
modification might result in detection of new potential antirheumatic drugs having antimicrobial activities.  
Method: A series of novel 4-(5′-substituted aryl-4′, 5′-dihydropyrazole-3′-yl-amino) phenols 2a-f have 
been synthesized by treating substituted aryl-N-chalconyl amino phenols 1a-f with hydrazine hydrate. 
The starting materials were synthesized from p-aminoacetophenone. Their structures were confirmed by 
IR, 
1
H NMR spectral data. The synthesized compounds were investigated for analgesic, ant-
inflammatory and antimicrobial activities. 
Result: The data reported in Tables 2, 3 & 4 shows that effect of variation in chemical structure on 
activity was rather unpredictable. Seldom did a particular structural modification lead to uniform 
alteration in activity in all tests. The substitution which appeared to be most important for high order of 
activity in the greatest number of test was the p-choloroaryl group. The introduction of p-nitro and p-
hydroxy group in aryl moiety of the pyrazole analogs 2c and 2e produce compounds with potent 
analgesic, anti-inflamatory and, in a few cases, antimicrobial properties.   
Conclusion: The observed increase in analgesic, anti-inflammatory and antimicrobial activities are 
attributed to the presence of 4-NO2, 2-OH and 4-Cl in phenyl ring at 5-position of pyrazoline ring of 
synthesized compounds. In some cases their activities are equal or more potent than the standard 
drugs.   
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INTRODUCTION 
Pyrazole derivatives have a long history of 
application in agrochemicals and 
pharmaceutical industry as herbicides and 
active pharmaceuticals. The recent success of 
pyrazole COX-2 inhibitor has further 
highlighted the importance of these 
heterocycles in medicinal chemistry. A 
systematic investigation of this class of 
heterocyclic lead revealed that pyrazole 
containing pharmacoactive agents play 
important role in medicinal chemistry. The 
prevalence of pyrazole cores in biologically 
active molecules has stimulated the need for 
elegant and efficient ways to make these 
heterocyclic lead. The treatment of pain 
continues to be the subject of considerable 
pharmaceutical and clinical research. 
Microbial infections often produce pain and 
inflammation. Chemotherapeutic, analgesic 
and anti-inflammatory drugs are prescribed 
simultaneously in normal practice. The 
compound possessing all three activities is not 










 activities. In view of these 
above, an attempt has been undertaken for 
the synthesis of the some novel 4-(5′-
substituted aryl-4′, 5′-dihydropyrazole-3′-yl-
amino) phenols possessing potent biological 
activities. The synthesized compounds were 
tested for their possible analgesic, anti-




Melting points were determined in open 
capillaries and were uncorrected by melting 
point determining apparatus (SISCO). Purity 
of the compounds were checked by TLC. IR 
spectra (KBr, cm
-1
) were recorded on a 
JASCO FT/IR 410 spectrophotometer. 
1
H 
NMR (CDCl3) on a Bruker DPX 300-MHz 
spectrometer using TMS as an internal 
reference (chemical shifts in δ ppm). C, H and 





Pure paracetamol (ODCL,India), ciprofloxacin 
(Alkem,India), clotrimazole (Glenmerk,India). 
Methanol, Hydrazinehydrate, ethanol (all from 
(SD-Fine Chemical, India), Sodium Hydroxide 
benzaldehyde, furfuraldehyde, 4-
nitrobenzaldehyde,  p-anisaldehyde, 
salicylaldehyde, 4-cholorobenzaldehyde, 
Carrageenan (all from Merck, Germany), 
carboxymethylcellulose (Sigma, India), 
Dimethylformamide (Aldrich), Mullar hinton 





To a mixture of p-hydroxyacetoaminophenone 
(0.01 mol) and benzaldehyde (0.01 mol) in 
ethanol, 2 % sodium hydroxide solution (1 ml) 
was added drop wise with constant stirring  
over a period of 30 min. and the reaction 
mixture was stirred for another 10 h at room 
temperature and then refluxed for 6 h. The 
excess solvent was distilled off and the solid 
obtained was poured into ice- cold water. The 
solid thus obtained was filtered, dried and 
recrystallised from ethanol. Compounds 1b-f 
were prepared similarly by using different 
arylaldehydes. Their melting points, % yields 
and molecular formula are given in Table-1  
1a  (R = -C6 H5): m.p. 150
0
c, yield: 72%, 
IR(KBr in cm
-1
) : 3452 (Ar–OH str.), 3301 (NH 
str.), 3016 (C-H str.), 1610 (C=C str.), 
1
H- 
NMR (δ ppm) (CDCl3), 7.1-7.8 (2H,d,CH), 
6.11 (1H,s,N-H), 7.70 (1H,s,N-H), 5.35 (1H, s, 
Ar-OH),6.76 – 8.00 (m, Ar-H ). Analysis 
(C15H13O2N ) cal(found)%: C 75.30(75.52) 
H5.48(4.98) N5.85(6.21).,MS:(m/z) : 239(M
+
). 
1b (R = - Furyl): IR(KBr in cm
-1
) :  3300 (Ar–
OH str.), 3253 (NH str.), 2922 (CH2 str.), 
1476(C=C str.), 1137 (C-O-C str.);
 1
H- NMR (δ 
ppm) (CDCl3), 7.13-7.21(2H,d,CH), 6.21 
(1H,s,N-H), 7.38 (1H, s, N-H),,5.65 (1H, s, Ar-
OH),6.76 – 8.00 (m, Ar-H ). Analysis 
(C13H11O3N) )cal(found)%: C 68.11(68.43) H 
4.84(4.49)  N 6.11(5.89).,MS:(m/z): 229. 1c 
(R=p-NO2-C6H4):- IR(KBr in cm
-1
) :  3490 (Ar-
OH str.), 3291 (NH str.), 3099 (C-H str.), 
2851(CH2 str.), 1560 (C- NO2 asym. str.), 
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1485(C=C str.); .), 
 1
H- NMR (δ ppm) (CDCl3), 
7.1-7.8 (2H,d,CH), 6.13(1H,s,N-H), 7.68 
(1H,s, N-H), 5.35 (1H, s, Ar-OH),6.76 – 8.02 
(m, Ar-H ) Analysis (C15H12O4N2) cal(found)%: 
C 63.38(63.42) H 4.25(4.52) N 9.85(9.53). MS 
:( m/z) 284(M
+
). 1d (R = p- OCH3-C6H4 ) 
IR(KBr in cm
-1
) : 3431(Ar-OH str.), 3211 (NH 
str.), 2831 (CH2 str), 1493(C=C str), 1101(C-
O-C str); 
1
H- NMR (δ ppm) (CDCl3 ) 7.1-7.8 
(2H,d,CH), 6.14 (1H,s,N-H), 7.52 (1H, s, N-H), 
5.35 (1H, s, Ar-OH),6.76 – 8.01.(m, Ar-H ). ):- 
Analysis (C16H15O3N) cal (found) %: C 
71.36(71.57) H 5.61(6.02) N 5.20(4.99). 
MS:(m/z): 269(M
+
).1e (R= 2-OH-C6 H4 ):- 
IR(KBr in cm
-1
) : 3412 (Ar-OH str.),3208(NH 
str.), 2834(CH2 str.), 1505.7(C=C str.);
 1
H- 
NMR (δ ppm) (CDCl3), 7.1-7.8 (2H,d,CH), 
6.23 (1H,s,N-H), 7.48 (1H, s, N-H), 5.35 (1H, 
s, Ar-OH),6.56 – 8.00 (m, Ar-H ) Analysis 
(C15H13O3N) cal(found)%: C 70.58(70.82) H 
5.13(5.34)  N 5.49(5.26). MS :( m/z) 255(M
+
). 
1f (R = p-Cl-C6H4): IR (KBr in cm
-1
): 3417(Ar-
OH str.), 3278(NH str.), 2932 (C-H str.), 




H- NMR (δ ppm) 
(CDCl3), 7.19-7.21 (2H, d, CH), 6.21(1H, s, N-
H), 7.40 (1H, s, N-H), 5.38 (1H, s, Ar-OH), 
6.76 – 8.00 (m, Ar-H ). Analysis 
(C15H12O2NCl) cal (found) %: C 65.82(66.12) 





Preparation of 4-[(5′-phenyl-4′, 5′-
dihydropyrazol-3′-yl) amino] phenol (2a) 
A mixture of compound 1a (0.01mol) and 
hydrazine hydrate (0.01mol) in ethanol (30ml), 
were refluxed for 6 h on a water bath. The 
reaction mixture was concentrated, cooled 
and poured into ice-cold water. The resulting 
solid 2a was filtered, dried and recrystallised 
from ethanol. Compounds 2b-f were prepared 
similarly. Their melting points, % yields and 
molecular formula are given in Table-1.  2a(R 
= -C6 H5):  IR (KBr in cm
-1
): 3462 (Ar–OH str.), 
3293 (NH str.), 3261(NH str.), 3022(C-H str.), 
1630 (C=N str.), 
1
H- NMR (δ ppm) (CDCl3), 
2.20-2.25 (1H, t, CH), 6.15 (1H,s,N-H),  7.43 
(1H, d, N-H), 4.71- 4.86 (2H, d, CH2), 5.31 
(1H, s, Ar-OH), 7.31 – 7.65 ( m, Ar-H ). 
Analysis (C15H15N3O) cal (found) %: C 
71.13(70.75) H 5.97(5.76) N 16.59(16.39). MS 
:( m/z): 253(M
+
). 2b (R=Furyl): IR (KBr in cm
-
1
):  3312 (Ar–OH str.), 3261 (NH str.), 3264 
(NH str.), 3065 (O-H str.), 2927 (CH2 str.), 
1630 (C=N str.), 1464 (C=C str.), 1137 (C-O-C 
str.); 
1
H- NMR (δ ppm) (CDCl3),2.13-2.22 (1H, 
t, CH), 6.24 (1H,s,N-H), 7.38 (1H, d, N-H), 
4.54- 4.61 (2H, d, CH2), 5.63 (1H, s, Ar-OH), 
6.63 – 7.87 ( m, Ar-H ). Analysis (C13H13N3O2) 
cal (found) %: C 64.19(64.23) H 5.39(4.99) N 
12.27(12.63).MS :( m/z) 243 (M
+
). 2c (R = p-
NO2-C6H4 IR(KBr in cm
-1
) : 3497 (Ar-OH str.), 
3298 (NH str.), 3241 (NH str.), 3073 (C-H str.), 
2832 (CH2 str.), 1634 (C = N str.), 1570 (C- 
NO2 asym. str.), 1489 (C=C str.); 
1
H- NMR (δ 
ppm) (CDCl3),2.22-2.24 (1H, t, 
CH),/6.11(1H,s,N-H), 7.68 (1H,d, N-H), 4.11- 
4.16 (2H, d, CH2), 5.28 (1H, s, Ar-OH), 6.78 – 
8.24 ( m, Ar-H ). ):- Analysis (C15H14N4O3) 
cal(found)% : C 60.40 (60.49) H 4.73 (4.87) N 
18.78 (18.43). MS :( m/z) 298(M
+
). 2d (R = p- 
OCH3-C6H4):- IR(KBr in cm
-1
) :  3431 (Ar-OH 
str.), 3207 (NH str.), 2843 (CH2 str), 1613 
(C=N str), 1499 (C=C str), 1093 (C-O-C str); 
1
H- NMR (δ ppm) (CDCl3),2.1-2.4 (1H, t, CH), 
6.17(1H,s,N-H), 7.52 (1H, d, N-H), 4.36- 4.41 
(2H, d, CH2), 5.47 (1H, s, Ar-OH), 6.71 – 8.11 
( m, Ar-H ). Analysis (C16H17N3O2.) cal (found) 
%: C 67.83 (68.01) H 6.05 (5.88) N 14.83 
(14.72).  MS:(m/z) 283(M
+
).2e (R=2-OH-
C6H4):- IR(KBr in cm
-1
) : 3409 (Ar-OH 
str.),3202 (NH str.), 2834 (CH2 str.), 1638 
(C=N str.), 1500 (C=C str.) ; 
1
H- NMR (δ ppm) 
(CDCl3),2.12-2.6 (1H, t, CH), 6.26 (1H,s,N-H), 
7.48 (1H, d, N-H), 4.15- 4.18 (2H, d, CH2), 
5.34 (1H, s, Ar-OH), 6.68 – 8.13 ( m, Ar-H ). 
Analysis (C15H15N3O2) cal (found) %: C 
66.96(66.64) H 5.61(5.47), N 15.60 (15.34). 
MS :( m/z) 269 (M
+
). 2f (R=p-Cl-C6H4): IR(KBr 
in cm
-1
) :  3411 (Ar-OH str.), 3271 (NH str.), 
2922 (C-H str.), 2922 (CH2 str.), 1024 (C=N 
str.), 742  (C-Cl str.), 
1
H- NMR (δ ppm) 
(CDCl3),2.21-2.23 (1H, t, CH), 6.24(1H,s,N-
H),7.43 (1H, d, N-H), 4.23- 4.28 (2H, d, CH2), 
5.46 (1H, s, Ar-OH), 6.82 – 8.16 ( m, Ar-H ). 
Analysis (C15H14N3OCl) cal (found) %: C 





Wistar albino mice (20-30 g) and Swiss albino 
rats (100 – 140 g) of either sex were selected 
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for the experiments. Animals were allowed to 
be acclimatise for a period of 2 weeks in our 
laboratory environment prior to the study. 
Animals were housed in polypropylene cages 
(4 animals per cage), maintained under 
standard laboratory conditions (i.e. 12:12 hour 
light and dark sequence; at an ambient 
temperature of 25±2ºC; 35-60% humidity); the 
animals were fed with standard rat pellet diet 
(Hindustan Liver Ltd.Mumbai) and water ad 
libitum. The principles of Laboratory Animal 
Care (NIH, 1985) were followed and 
instructions given by our institutional animal 
ethical committee were maintained throughout 
the experiment.   
Analgesic activity  
The analgesic activity was determined by 
tail flick method 
7
. Wistar albino mice of 
either sex (20-30g) in the groups of six 
animals each were selected by random 
sampling technique. Paracetamol at a dose 
level of 100 mg/kg was administered as a 
reference drug for comparison. The test 
compounds at dose level of 100mg/kg were 
administered orally by intragastric tube. The 
animals were held in position by a suitable 
restrained with the tail extending out and the 
tail (up to 5 cm) was then dipped in a beaker 
of water maintained at 55 ± 5 
0
C. The time 
in seconds taken to withdraw the tail clearly 
out of water was taken as the reaction time. 
The reading was recorded at 30, 60, 120 
and 180 min. after administration of 
compounds. A cut off point of 10 sec. was 
observed to prevent the tail damage. The 
results are presented in Table-2. 
Anti-inflammatory activity  
The anti-inflammatory activity was determined 
by carrageenan-induced rat paw oedema 
method 
7
 in abino rats (n=6) of eiher sex (100-
140 g). Rats were selected by random 
sampling technique. Paracetamol (100mg/kg) 
was administered as a reference drug. The 
test compounds were administered at dose 
level of 100 mg/kg orally 30 min. prior to the 
administration of carrageenan in the right hind 
paw of the rats. The paw thickness was 
measured using vernier callipers at 30, 60, 
120 and 180 min. after carrageenan 
administration. The results are presented in 
Table-3. 
Antimicrobial activity  
In vitro antimicrobial study was carried on 
Muller hinton agar (Hi-media) plates (37 
0
C, 
24 h) by agar diffusion cup plate method 
8
. 
All the compounds were screened for 
antimicrobial activity at 100 µg/ml 
concentration against the following bacterial 
strains: Staphylococcus aureus, 
Staphylococcus feacalis, Escherichia coli, 
and Salmonella typhi. Antifungal activity was 
tested on Sabouraud dextrose agar (Hi-
media) plates (26 
0
C, 48-72 h) by cup plate 
method 
8 
against Candida albicans and 
Aspergillus niger at the concentration level 
of 100 µg/ml, Ciprofloxacin and Clotrimazole 
were used as a standards for comparison of 
antibacterial and antifungal activity under 
the similar conditions. DMF was used as a 
solvent control for both antibacterial and anti 
fungal activities. The results are presented 
in Table-4. 
Statistical analysis  
Data were analyzed by one –way ANOVA 
followed by Dunnett’s t-test using 
computerized Graph Pad Instat version 3.05 
(Graph Pad software, U.S.A.). 
 
RESULTS 
Biological results are reported in Table 2, 3 
and 4, which also records the effects of the 
standard drug included for comparison, Series 
of compound are prepared in this study 
exhibited significant pharmacological 
properties in different biological models. The 
general pattern of pharmacological activity 
encountered in this synthesized compounds 
was seen mainly in their effect on pain 
perception and local inflamation.However, 
there was a small, well defined antimicrobial 
activity range associated with many of these 
compounds. Considerable variation of these 
effects were seen with each structural change, 
varying from agents that had less activity to 
those with high potency, and significant 
changes in potency resulted even from minor 
change in chemical structure as shown in 
Table2,3  and 4.  
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Analgesic Activity: Some of the compounds 
in this series exhibited activity in experimental 
models used. The particular interests are the 
results obtained in the Glassman’s procedure 
which utilizes selective inhibition of 
inflammatory pain as a creation for anti-
inflammatory drugs. When the structure of this 
synthesized compound is compared, it would 
appear that replacement in R with a p-nitro, p-
methoxy and p-choloro aryl groups (2c, 2e 
&2f) showed promising analgesic activity. 
Anti-inflammatory Activity: A number of 
agents caused marked reduction of the 
carrageenan induced edema of the rat foot, 
however, with exception of compounds 2f (R = 
p-Nitro phenyl). In this test also only analogs 
with a p-Methoxy phenyl group in R (2d) 
showed equal to that exhibited by the 
standard paracetamol .Compounds 2f, in 
 











   Compound      (R)    Mol. Form.            M.P. (0C)            Yield (%)     
 
1a  -C6H5   C15H13O2N  148-150         72 
1b  -2-furyl           C13H11O3N  160-162         63 
1c  -4-NO2-C6H4  C15H12O4N2           108-110         81 
1d  -4-OCH3-C6H4  C16H15O3N           152-154         74  
1e  -2-OH-C6H4  C15H13O3N  142-144         72 
1f  -4-Cl-C6H4  C15H12O2NCl  150-152         75 
2a  -C6H5   C15H15N3O  161-163         62 
2b  -2-furyl   C13H13N3O2  159-161         73 
2c  -4-NO2-C6H4  C15H14N4O3  182-184         69 
2d  -4-OCH3-C6H4  C16H17N3O2            143-145         72 
2e  -2-OH-C6H4  C15H15N3O2  164-166         66 
2f  -4-Cl-C6H4  C15H14N3OCl  190-192         78 
 
 
Table 2: Analgesic activity (tail flick method) of compounds 2a-f 
 
      Compd.           Dose                        Percentage of analgesic activity 
                mg/kg        30 min.             1 hour                2 hour                  3 hour  
 
2a              100      27 ± 0.12
*
        30 ± 0.23
*
         35 ± 0.43
*
    30±0.11
* 
2b              100      33± 0.25
*
         42± 0.09
**
         44± 0.40
*
    38 ± 0.31
*
 
2c  100      38 ± 0.54
**
       43± 0.23
**
         47 ± 0.43
**
            38± 0.29
* 
2d  100      44 ± 0.23
*
        53 ± 0.29
**
        58 ± 0.33
*
  45 ± 0.36
* 
2e   100                   36 ± 0.32
*
        43 ±0.36
**
         47± 0.38
**
  38± 0.42
** 
2f  100     42± 0.23
**
        45± 0.73
**
          50± 0.87
** 
    38± 0.65
** 
Paracetamol 100     38± 0.42
**
        47± 0.82
**
          52± 0.71
**
   33 ± 0.31
** 
 Control     _      3 ± 0.26            6 ± 0.44          4 ± 0.57               4 ± 0.91 
Results are expressed in mean ± SEM (n=6) significance levels * P<0.05, 
** 
P < 0.01 and 
***
 P < 0.001 as compared 
with the respective control. 
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addition to being the most potent agents of 
this series against rat-foot inflammation, were 
also found to be among the most active 
analgesic when assayed in Glassman’s 
analgesic model. 
Antimicrobial Activity: The in-vitro 
antimicrobial activity of compounds (2a-f) 
were determined by agar cup plate method, 
The results of which are summarized in Table 
4.The antimicrobial data in table 4 clearly 
showed that the halogen, nitro & hydroxyl 
phenyl groups is by far the most active 
substituted R group. The methoxy group 
generally confers week antimicrobial activity. 
Phenyl and Furyl substitution are weakly 
active to inactive among the synthesized 
compounds. Compounds 2c, 2e and 2f 
showed good activity against S. aureous and 
S. typhi. The compound 2c& 2f exhibit 
promising activity against C. albicans and A. 
niger. However, the tested compounds were 
less active in comparison to Ciprofloxacin and 





Table 3:  Anti-inflammatory activity (carrageenan induced rat paw oedema method) of 
compounds 2a-f. 
 
Compd.       Dose                 Percentage inhibition  
   mg/kg    30 min.            1 hour              2 hour             3 hour         
 






















































Control     -  5.11± 0.28 6.13± 0.26 5.68± 0.36 3.30± 0.91 






   28± 0.62
 ** 
Results are expressed in mean ± SEM. (n=6) significance levels * P<0.05, 
** 
P < 0.01 and 
***
 P < 0.001 as compared 
with the respective control. 
 
   
 Table 4:  Antibacterial and antifungal activity of compounds 2(a-f) 
         Compd.       Conc.(µg/ml)        Zone   of   inhibition (mm) 
 S. a    S. f      E. c        S. t  C. a        A. n  
2a  100  14    16      16         12  13     13 
2b  100  13    12      15         11   12     11 
2c  100  18    20      21         19   17     19 
2d  100  16    15      17         14   14     13 
2e  100  21    16      17         19   20     17 
2f  100  18    18      19         18    21     24  
  Ciprofloxacine   10  29    31      32         26    -      - 
  Clotrimazole  20   -     -        -            -   28     27 
*Average of three readings  
S. a = Staphylococcus aureus; S.f = Staphylococcus faecalis; E. c = Escherichia coli; S. t = Salmonella typhi; C. a = 
Candida albicans; A. n = Aspergillus niger 
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The purpose of the present study was to 
examine whether molecular modification might 
result in detection of new potential 
antirheumatic drugs. A series of compounds 
were prepared and assayed in a variety of 
biological test for analgesic, anti-inflammatory 
and antimicrobial activity. The data reported in 
Table 2, 3 & 4 shows that effect of variation in 
chemical structure on activity was rather 
unpredictable. Seldom did a particular 
structural modification lead to uniform 
alteration in activity in all tests. However some 
point of interest did emerge and a few 
generalizations can be made. The substitution 
which appeared to be most important for high 
order of activity in the greatest number of test 
was the p-choloroaryl group. The introduction 
of Para nitro and p-hydroxy group in aryl 
moiety of the pyrazole analogs 2c and 2e 
produce compounds with potent analgesic, 




In conclusion, the results of this investigation 
revealed that the observed increase in 
analgesic, anti-inflammatory and antimicrobial 
activities are attributed to the presence of 4-
NO2, 2-OH and 4-Cl in phenyl ring at 5-
position of pyrazoline ring of synthesized 
compounds. .Obviously, the comparative 
evaluation of active compounds will required 
further studies; the data reported in this article 
may be helpful guide for the medicinal chemist 























    DISCUSSION 
 
Fig 1:     R   = -C6H5 (1a, 2a) 
   -2-furyl (1b, 2b) 
   -4-NO2-C6H4 (1c, 2c) 
   -4-OCH3-C6H4 (1d, 2d) 
   -2-OH-C6H4 (1e, 2e) 
   -4-Cl-C6H4 (1f, 2f) 
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